HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,143,537 | -20.1% | 126,443 | -14.2% | 0.00% | 0.0% |
| Q2 2023 | $5,188,027 | -83.3% | 147,429 | -84.6% | 0.00% | -88.9% |
| Q1 2023 | $31,158,908 | -66.3% | 954,331 | -43.1% | 0.01% | -66.7% |
| Q4 2022 | $92,335,258 | +78.2% | 1,675,776 | +43.3% | 0.03% | +58.8% |
| Q3 2022 | $51,808,000 | +308.5% | 1,169,735 | +349.8% | 0.02% | +325.0% |
| Q2 2022 | $12,683,000 | +28.9% | 260,058 | +28.5% | 0.00% | +33.3% |
| Q1 2022 | $9,843,000 | +109.2% | 202,308 | +83.3% | 0.00% | +200.0% |
| Q4 2021 | $4,706,000 | +1200.0% | 110,361 | +1066.7% | 0.00% | – |
| Q3 2021 | $362,000 | +70.0% | 9,459 | +25.3% | 0.00% | – |
| Q2 2021 | $213,000 | – | 7,548 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |